1081 related articles for article (PubMed ID: 11146273)
21. Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea.
Lee S; Chang YJ; Cho H
BMC Med Res Methodol; 2021 Apr; 21(1):66. PubMed ID: 33836666
[TBL] [Abstract][Full Text] [Related]
22. Developing a claim-based version of the ACE-27 comorbidity index: a comparison with medical record review.
Fleming ST; Sabatino SA; Kimmick G; Cress R; Wu XC; Trentham-Dietz A; Huang B; Hwang W; Liff J
Med Care; 2011 Aug; 49(8):752-60. PubMed ID: 21490514
[TBL] [Abstract][Full Text] [Related]
23. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records.
Newcomer R; Clay T; Luxenberg JS; Miller RH
J Am Geriatr Soc; 1999 Feb; 47(2):215-9. PubMed ID: 9988293
[TBL] [Abstract][Full Text] [Related]
24. Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms.
Randolph WM; Mahnken JD; Goodwin JS; Freeman JL
Health Serv Res; 2002 Dec; 37(6):1643-57. PubMed ID: 12546290
[TBL] [Abstract][Full Text] [Related]
25. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
[TBL] [Abstract][Full Text] [Related]
26. The James A. Rand Young Investigator's Award: Administrative Claims vs Surgical Registry: Capturing Outcomes in Total Joint Arthroplasty.
Patterson JT; Sing D; Hansen EN; Tay B; Zhang AL
J Arthroplasty; 2017 Sep; 32(9S):S11-S17. PubMed ID: 28185755
[TBL] [Abstract][Full Text] [Related]
27. Assessing comorbidity using claims data: an overview.
Klabunde CN; Warren JL; Legler JM
Med Care; 2002 Aug; 40(8 Suppl):IV-26-35. PubMed ID: 12187165
[TBL] [Abstract][Full Text] [Related]
28. The development and validation of a comorbidity index for prostate cancer among Black men.
Fleming ST; Pearce KA; McDavid K; Pavlov D
J Clin Epidemiol; 2003 Nov; 56(11):1064-75. PubMed ID: 14614997
[TBL] [Abstract][Full Text] [Related]
29. Construct validity of medicare chemotherapy claims: the case of 5FU.
Lamont EB; Lauderdale DS; Schilsky RL; Christakis NA
Med Care; 2002 Mar; 40(3):201-11. PubMed ID: 11880793
[TBL] [Abstract][Full Text] [Related]
30. Trends in Medicare enrollee use of physician and supplier services, 1983-86.
Fisher CR
Health Care Financ Rev; 1988; 10(1):1-15. PubMed ID: 10312816
[TBL] [Abstract][Full Text] [Related]
31. Health Care Resource Use, Costs, and Diagnosis Patterns in Patients With Schizophrenia and Bipolar Disorder: Real-world Evidence From US Claims Databases.
Broder MS; Greene M; Chang E; Hartry A; Touya M; Munday J; Yan T
Clin Ther; 2018 Oct; 40(10):1670-1682. PubMed ID: 30193748
[TBL] [Abstract][Full Text] [Related]
32. Systematic screening of secondary diagnoses in Medicare administrative data to identify candidate risk factors for the principal diagnosis.
Baine WB
Ann Epidemiol; 2003 Jul; 13(6):443-9. PubMed ID: 12875803
[TBL] [Abstract][Full Text] [Related]
33. Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States.
Kearney M; Thokagevistk K; Boutmy E; Bharmal M
J Med Econ; 2018 Dec; 21(12):1159-1171. PubMed ID: 30149739
[TBL] [Abstract][Full Text] [Related]
34. Using Medicare data to estimate the number of cases missed by a cancer registry: a 3-source capture-recapture model.
McClish D; Penberthy L
Med Care; 2004 Nov; 42(11):1111-6. PubMed ID: 15586838
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures.
Katz JN; Barrett J; Liang MH; Bacon AM; Kaplan H; Kieval RI; Lindsey SM; Roberts WN; Sheff DM; Spencer RT; Weaver AL; Baron JA
Arthritis Rheum; 1997 Sep; 40(9):1594-600. PubMed ID: 9324013
[TBL] [Abstract][Full Text] [Related]
36. Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.
Gilbertson DT; Bradbury BD; Wetmore JB; Weinhandl ED; Monda KL; Liu J; Brookhart MA; Gustafson SK; Roberts T; Collins AJ; Rothman KJ
Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):269-77. PubMed ID: 26608680
[TBL] [Abstract][Full Text] [Related]
37. Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims.
Asch SM; Sloss EM; Hogan C; Brook RH; Kravitz RL
JAMA; 2000 Nov; 284(18):2325-33. PubMed ID: 11066182
[TBL] [Abstract][Full Text] [Related]
38. Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer.
Bronson MR; Kapadia NS; Austin AM; Wang Q; Feskanich D; Bynum JPW; Grodstein F; Tosteson ANA
Med Care; 2018 Dec; 56(12):e83-e89. PubMed ID: 29334524
[TBL] [Abstract][Full Text] [Related]
39. Ability of Medicare claims data to identify nursing home patients: a validation study.
Koroukian SM; Xu F; Murray P
Med Care; 2008 Nov; 46(11):1184-7. PubMed ID: 18953230
[TBL] [Abstract][Full Text] [Related]
40. Do claims-based comorbidities adequately capture case mix for surgical site infections?
Maradit Kremers H; Lewallen LW; Lahr BD; Mabry TM; Steckelberg JM; Berry DJ; Hanssen AD; Berbari EF; Osmon DR
Clin Orthop Relat Res; 2015 May; 473(5):1777-86. PubMed ID: 25480123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
